SCAMP1 silencing inhibits proliferation by attenuating multiple pro-survival signaling pathways in gastric cancer

Gang Ma1, Yang Yang2, Fenglin Cai1

  • 1Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer; Tianjin Key Laboratory of Digestive Cancer, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, P. R. China.

Journal of Cancer
|September 23, 2024
PubMed

Insights

Secretory carrier-associated membrane protein 1 (SCAMP1) drives gastric cancer (GC) cell hyperproliferation. SCAMP1 knockdown suppressed tumor growth and revealed its role in key signaling pathways, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Secretory carrier-associated membrane protein 1 (SCAMP1) facilitates endocytosis but its role in cancer is largely unknown.
  • SCAMP1 expression is elevated in most cancer types, including gastric cancer (GC).

Purpose of the Study:

  • To investigate the expression and function of SCAMP1 in gastric cancer.
  • To determine the prognostic significance of SCAMP1 in GC patients.
  • To elucidate the molecular mechanisms underlying SCAMP1-driven GC progression.

Main Methods:

  • Analysis of SCAMP1 expression in GC tissues.
  • In vitro and in vivo functional assays following SCAMP1 knockdown.
  • RNA sequencing to identify altered gene expression profiles.
  • Western blotting to assess signaling pathway activation.

Main Results:

  • SCAMP1 expression was significantly increased in GC tissues and correlated with tumor size and lymph node metastasis.
  • Increased SCAMP1 expression was associated with poor prognosis in GC patients.
  • SCAMP1 knockdown suppressed GC cell proliferation in vitro and in vivo.
  • SCAMP1 depletion altered gene expression, particularly in receptor tyrosine kinase pathways, and attenuated the Akt/MAPK/Stat signaling pathway.

Conclusions:

  • SCAMP1 drives hyperproliferation in gastric cancer cells.
  • SCAMP1 represents a potential therapeutic target for gastric cancer.
  • Further research into SCAMP1's mechanisms and translational value in GC is warranted.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K